/
Other
Health Adult Subjects
6
Pipeline Programs↗
6
Active Trials↗
4
Companies Involved↗
Health Adult Subjects is an early-stage landscape with 6 programs across 4 companies. The most active players are Biotech Pharmaceutical Co., Ltd., Helixon Biotechnology (Suzhou) Co., Ltd.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 15
Phase 2
No programs
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
15
clinical trials
Completed9 · 60%
Not yet recruiting3 · 20%
Recruiting3 · 20%
Clinical Trials
Trial Activity
15 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)